HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Françoise Redini Selected Research

apomine (SR 45023A)

2/2012Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Françoise Redini Research Topics

Disease

28Neoplasms (Cancer)
01/2022 - 10/2006
22Osteosarcoma (Osteogenic Sarcoma)
03/2022 - 12/2005
11Neoplasm Metastasis (Metastasis)
01/2018 - 12/2005
8Bone Resorption
01/2016 - 11/2003
7Ewing Sarcoma (Sarcoma, Ewing)
12/2016 - 10/2010
5Osteolysis
06/2015 - 11/2003
4Sarcoma (Soft Tissue Sarcoma)
01/2016 - 01/2012
3Chondrosarcoma
11/2012 - 09/2009
2Bone Neoplasms (Bone Cancer)
03/2022 - 01/2019
2Bone Diseases (Bone Disease)
11/2008 - 12/2001
1Hypoxia (Hypoxemia)
03/2022
1Breast Neoplasms (Breast Cancer)
11/2019
1Necrosis
01/2017
1Bisphosphonate-Associated Osteonecrosis of the Jaw
09/2016
1Adenocarcinoma
01/2014
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2014
1Inflammation (Inflammations)
06/2013
1Neuroblastoma
11/2012
1Glioma (Gliomas)
11/2012
1Medulloblastoma
11/2012
1Carcinoma (Carcinomatosis)
02/2008

Drug/Important Bio-Agent (IBA)

7Zoledronic Acid (Zometa)FDA Link
01/2019 - 12/2005
6Biological ProductsIBA
01/2022 - 01/2006
5Diphosphonates (Bisphosphonates)IBA
09/2016 - 12/2005
5OsteoprotegerinIBA
09/2013 - 12/2001
4CytokinesIBA
01/2018 - 01/2015
4Proteoglycans (Proteoglycan)IBA
04/2013 - 09/2009
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2017
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2016 - 01/2011
2Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 01/2018
2RNA (Ribonucleic Acid)IBA
01/2022 - 12/2020
2TNF-Related Apoptosis-Inducing LigandIBA
01/2018 - 12/2016
2CaspasesIBA
01/2018 - 12/2016
2LigandsIBA
01/2018 - 11/2008
2IfosfamideFDA LinkGeneric
01/2018 - 01/2017
2Transforming Growth Factors (Transforming Growth Factor)IBA
11/2016 - 10/2014
2mifamurtideIBA
01/2016 - 02/2011
2Pharmaceutical PreparationsIBA
02/2015 - 02/2011
2Cytostatic AgentsIBA
02/2015 - 11/2012
2EWS-FLI fusion proteinIBA
04/2013 - 11/2012
2EnzymesIBA
11/2008 - 11/2003
2RANK LigandIBA
10/2006 - 11/2003
12-toluenesulfonamide (OTS)IBA
03/2022
1SialomucinsIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Verteporfin (Visudyne)FDA Link
12/2020
1Epinephrine (Adrenaline)FDA LinkGeneric
11/2019
1LipidsIBA
11/2019
1Conditioned Culture MediaIBA
11/2019
1Therapeutic UsesIBA
01/2019
1ProdrugsIBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018
1Etoposide (VP 16)FDA LinkGeneric
01/2018
1Cisplatin (Platino)FDA LinkGeneric
01/2017
1Apoptosis Inducing FactorIBA
12/2016
1Ethanolamine (Colamine)IBA
01/2016
1halofuginoneIBA
06/2015
1AlpelisibIBA
02/2015
1Adenosine Triphosphate (ATP)IBA
02/2015
1SD-208IBA
10/2014
1Imatinib Mesylate (Gleevec)FDA Link
01/2014
1Tyrosine Kinase InhibitorsIBA
01/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2014
1Monoclonal AntibodiesIBA
01/2014
1AerosolsIBA
01/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014
1Metalloproteases (Metalloproteinases)IBA
06/2013
1DisintegrinsIBA
06/2013
1Connexin 43 (Connexin43)IBA
04/2013
1Transcription Factors (Transcription Factor)IBA
04/2013
1Proteins (Proteins, Gene)FDA Link
11/2012
1Oncostatin MIBA
11/2012
1apomine (SR 45023A)IBA
02/2012
1Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
02/2012
1Lovastatin (Mevacor)FDA LinkGeneric
02/2012
1GlycosaminoglycansIBA
01/2011
1Heparin (Liquaemin)FDA LinkGeneric
01/2011
1Messenger RNA (mRNA)IBA
01/2011
1Cathepsin KIBA
11/2008
1NF-kappa B (NF-kB)IBA
11/2008
1Caspase 3 (Caspase-3)IBA
02/2008
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
10/2006
1bone resorption factorIBA
11/2003
1ImmunosorbentsIBA
11/2003

Therapy/Procedure

11Therapeutics
01/2016 - 02/2007
7Drug Therapy (Chemotherapy)
01/2022 - 10/2010
1Oral Administration
01/2014
1Intravenous Injections
04/2013
1Curettage
09/2009